Judith I Tsui1, Marlene C Lira2, Debbie M Cheng3, Michael R Winter4, Daniel P Alford5, Jane M Liebschutz6, Robert R Edwards7, Jeffrey H Samet6. 1. Section of General Internal Medicine, Department of Medicine, Harborview Hospital/University of Washington School of Medicine, 325 9th Avenue, Box 359780, Seattle, WA 98104, United States. Electronic address: tsuij@uw.edu. 2. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States. 3. Department of Biostatistics, Boston University School of Public Health, 801 Massachusetts Ave., Third Floor, Boston, MA 02118, United States. 4. Data Coordinating Center, Boston University School of Public Health, 801 Massachusetts Ave., Third Floor, Boston, MA 02118, United States. 5. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States. 6. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States; Department of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave., Second Floor, Boston, MA 02118, United States. 7. Department of Anesthesia, Brigham and Women's Hospital, Pain Management Center, 850 Boylston Street, Chestnut Hill, MA 02467, United States.
Abstract
AIMS: In a sample of patients receiving opioid agonist therapy, we evaluated whether having chronic pain was associated with (a) craving for opioids and (b) illicit opioid use. METHODS: In a cross-sectional study of adults on buprenorphine or methadone maintenance recruited from an urban medical center, we examined any craving for opioids (primary dependent variable) in the past week and recent illicit opioid use (secondary dependent variable). Illicit opioid use was defined as a positive urine drug test (UDT) for opiates and chronic pain was defined as bodily pain that had been present for at least 3 months. Multivariable logistic regression models were fit for each outcome, adjusting for age, sex, and non-white race. Additional models adjusted for depression (PHQ-9) and anxiety (STAI). RESULTS: The sample included 105 adults on methadone or buprenorphine maintenance. Mean age was 43.8 (SD ±9.4)years; 48% were female and 32% non-white; 19% were on methadone. Chronic pain was present in 68% of the sample, 51% reported craving opioids in the past week, and 16% had a positive UDT. Chronic pain was associated with 3-fold higher odds of reporting craving in the past week (aOR=3.10; 95% CI: 1.28-7.50, p-value=0.01). The relative odds for having a positive UDT were not statistically significant (aOR=2.52; 95% CI: 0.64-9.90, p=0.18). CONCLUSION: In this sample of patients treated with opioid agonist therapy, those with chronic pain had higher odds of reporting craving for opioids. Chronic pain with associated opioid craving potentially places this population at risk for relapse.
AIMS: In a sample of patients receiving opioid agonist therapy, we evaluated whether having chronic pain was associated with (a) craving for opioids and (b) illicit opioid use. METHODS: In a cross-sectional study of adults on buprenorphine or methadone maintenance recruited from an urban medical center, we examined any craving for opioids (primary dependent variable) in the past week and recent illicit opioid use (secondary dependent variable). Illicit opioid use was defined as a positive urine drug test (UDT) for opiates and chronic pain was defined as bodily pain that had been present for at least 3 months. Multivariable logistic regression models were fit for each outcome, adjusting for age, sex, and non-white race. Additional models adjusted for depression (PHQ-9) and anxiety (STAI). RESULTS: The sample included 105 adults on methadone or buprenorphine maintenance. Mean age was 43.8 (SD ±9.4)years; 48% were female and 32% non-white; 19% were on methadone. Chronic pain was present in 68% of the sample, 51% reported craving opioids in the past week, and 16% had a positive UDT. Chronic pain was associated with 3-fold higher odds of reporting craving in the past week (aOR=3.10; 95% CI: 1.28-7.50, p-value=0.01). The relative odds for having a positive UDT were not statistically significant (aOR=2.52; 95% CI: 0.64-9.90, p=0.18). CONCLUSION: In this sample of patients treated with opioid agonist therapy, those with chronic pain had higher odds of reporting craving for opioids. Chronic pain with associated opioid craving potentially places this population at risk for relapse.
Authors: Judith I Tsui; Marlene C Lira; Debbie M Cheng; Michael R Winter; Daniel P Alford; Jane M Liebschutz; Jianren Mao; Robert R Edwards; Jeffrey H Samet Journal: Drug Alcohol Depend Date: 2015-05-22 Impact factor: 4.492
Authors: R Kathryn McHugh; Garrett M Fitzmaurice; Kathleen M Carroll; Margaret L Griffin; Kevin P Hill; Ajay D Wasan; Roger D Weiss Journal: Drug Alcohol Depend Date: 2014-10-16 Impact factor: 4.492
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin Journal: Am J Addict Date: 2013 May-Jun
Authors: Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Marc O Martel; Patrick H Finan; R Kathryn McHugh; Mohammed Issa; Robert R Edwards; Robert N Jamison; Ajay D Wasan Journal: Drug Alcohol Depend Date: 2016-03-18 Impact factor: 4.492
Authors: Mary Jo Larson; Michael Paasche-Orlow; Debbie M Cheng; Christine Lloyd-Travaglini; Richard Saitz; Jeffrey H Samet Journal: Addiction Date: 2007-05 Impact factor: 6.526
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh Journal: Nat Rev Dis Primers Date: 2020-01-09 Impact factor: 52.329
Authors: Patrick H Finan; Janelle Letzen; David H Epstein; Chung Jung Mun; Samuel Stull; William J Kowalczyk; Daniel Agage; Karran A Phillips; Diego A Pizzagalli; Kenzie L Preston Journal: Pain Med Date: 2021-09-08 Impact factor: 3.750
Authors: Ruiqi Tang; Katherine B Santosa; Joceline V Vu; Lewei A Lin; Yen-Ling Lai; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee Journal: Ann Surg Date: 2022-01-01 Impact factor: 12.969
Authors: Kimberly A DiMeola; Jeff Haynes; Meredith Barone; Mark Beitel; Lynn M Madden; Christopher J Cutter; Anthony Raso; Marina Gaeta; Xiaoying Zheng; Declan T Barry Journal: J Addict Med Date: 2022 Mar-Apr 01 Impact factor: 3.702